
Featured news
12 May 2022
Common steroids after ‘long Covid’ recovery may cut risk of death by up to 51%
By Mischa Dijkstra, Frontiers science writer Researchers show that severe inflammation during hospitalization for Covid-19 increases risk of death within one year from seeming recovery by 61%. This risk is reduced again by 51% if anti-inflammatory steroids are prescribed upon discharge. We need to think of Covid-19 as a potentially chronic disease that requires long-term management, argue the authors. Evidence continues to gather that ‘long Covid’, that is, continued negative health impacts months after apparent recovery from severe Covid-19, is an important risk for some patients. For example, researchers from the University of Florida Gainesville showed last December that hospitalized patients who seemingly recovered from severe Covid-19 run more than double the risk of dying within the next year, compared to people who experienced only mild or moderate symptoms and who had not been hospitalized, or who never caught the illness. Now, a team including some of the same authors shows for the first time that among patients hospitalized for Covid-19 who seemingly recovered, severe systemic inflammation during their hospitalization is a risk factor for death within one year. This may seem paradoxical, as inflammation is a natural part of the body’s immune response, which has evolved to fight infection. […]